Sign in

Debolina Ganguly

@debolina-ganguly.bsky.social
938 followers 207 following 5 posts

Parker Scholar | Post doc in Cancer Immunology at DFCI/HMS in Agudolab| PhD in Cancer biology from Brekkenlab at UTSW | 🇮🇳🇺🇸| she/her/hers

PostsRepliesMedia
Debolina Ganguly @debolina-ganguly.bsky.social · 19/04/2026
Had such a great time sharing my postdoc work and soaking in all the incredible science this week! Back to the lab feeling inspired! #AAI2026
000
Reposted by Debolina Ganguly
Johanna Joyce @johannajoyce.bsky.social · 16/04/2026
What does it take to truly understand #cancer in all of its complexity? Delighted to share our Review in Cell "Cancer ecosystems: A dynamic interplay across scales" with Daniela Quail, where we propose a multi-scale framework connecting tumor ecology with physiology 🧪⚕️ www.cell.com/cell/fulltex...
77433
Reposted by Debolina Ganguly
Judith Agudo @judithagudo.bsky.social · 05/03/2026
www.nature.com/articles/s41... The seeds of metastasis harness stress hormones to escape immune surveillance. So proud of this work! @harvardmed.bsky.social @danafarbernews.bsky.social @dfcibreastonc.bsky.social
nature.com
A glucocorticoid–FAS axis controls immune evasion during metastatic seeding - Nature
Glucocorticoid receptor activation is a key driver of resistance of triple-negative breast cancer to both CD8+ T cells and natural killer cells during initial metastatic seeding.
1103
Reposted by Debolina Ganguly
Barbara Marte @barbmarte.bsky.social · 22/01/2026
new out in Nature www.nature.com/articles/s41...
nature.com
Critical role for a high-plasticity cell state in lung cancer - Nature
The high-plasticity cell state (HPCS) is a critical hub that enables reciprocal transitions between cancer cell states, and targeting the HPCS may suppress cancer progression and eradicate treatment r...
0162
Reposted by Debolina Ganguly
Huocong Huang @huoconghuang.bsky.social · 25/09/2025
Our paper online now, CAF molecular phenotypes are more conserved than we thought across organs. Plus we now know more details about apCAFs. Please check it out 👉 Cancer Cell www.cell.com/cancer-cell/...
cell.com
Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches
Chen et al. identify two distinct antigen-presenting cancer-associated fibroblast (apCAF) populations across multiple cancer types. Mesothelial-related apCAFs locate near cancer cells while fibrocyte-...
0123
Debolina Ganguly @debolina-ganguly.bsky.social · 19/07/2025
The organ where the metastasis has spread matters! Check out our commentary on the recently published article by Cheng et al., @cp-cancercell.bsky.social @judithagudo.bsky.social
021
Reposted by Debolina Ganguly
Judith Agudo @judithagudo.bsky.social · 18/07/2025
www.sciencedirect.com/science/arti... Stellar postdoc @debolina-ganguly.bsky.social and I wrote this spotlight for a super cool paper on the systemic effects of metatasis. The organ of metastatic diseases makes A BIG difference! Highly recommended paper in @cp-cancercell.bsky.social
sciencedirect.com
Bone appetite: bone-derived factors feed distant immune suppression
The site of metastatic disease influences treatment response. A recent study in Cancer Cell by Cheng et al. revealed that bone metastases systemically…
031
Reposted by Debolina Ganguly
Jose M. Adrover @adrover.bsky.social · 17/07/2025
I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad.bsky.social lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13) www.nature.com/articles/s41...
nature.com
Neutrophils drive vascular occlusion, tumour necrosis and metastasis - Nature
Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.
36325
Reposted by Debolina Ganguly
Cancer Cell @cp-cancercell.bsky.social · 12/06/2025
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
dlvr.it
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
Cancer patients with bone metastases often exhibit resistance to immunotherapy. Cheng et al. discover that osseous tumors condition osteoclasts to produce osteopontin, which enters circulation and remotely suppresses precursor exhausted T cells within extraosseous tumors. Blocking RANKL attenuates this immunosuppressive communication, thereby enhancing patient responses to ICB therapy.
001
Debolina Ganguly @debolina-ganguly.bsky.social · 13/06/2025
🎉🎉🥳 couldn’t be more proud of my PI!!! 🤩
010
Reposted by Debolina Ganguly
NBC News @nbcnews.com · 30/05/2025
Harvard president receives standing ovation during commencement.
527330776741
Reposted by Debolina Ganguly
Marisol Soengas @msmelanoma.bsky.social · 29/03/2025
👍Yeah: Just out in @naturecancer.bsky.social from my lab @cniostopcancer.bsky.social Here, a video highlighting mechanisms of immune suppression in melanoma (hope you like the hot-to-cold shift via DCs) Implications for immune resistance in different tumor types below www.nature.com/articles/s43...
8406
Reposted by Debolina Ganguly
Johanna Joyce @johannajoyce.bsky.social · 31/03/2025
Why do brain metastases resist #immunotherapy — even when the same cancer responds outside the #brain? 🧠🧪💥 We just published a study diving into this question ⏬ Led by an amazing (former) PhD student in my lab —Vladimir Wischnewski 🎉 🧵 1/ @cp-cellreports.bsky.social www.cell.com/cell-reports...
58020
Reposted by Debolina Ganguly
Barbara Marte @barbmarte.bsky.social · 06/03/2025
new out in @nature.com www.nature.com/articles/s41...
nature.com
Evolutionary fingerprints of epithelial-to-mesenchymal transition - Nature
Malignant cells with mesenchymal features display increased chromatin accessibility, particularly in the pericentromeric and centromeric regions, in turn resulting in delayed mitosis and catastrophic ...
7167
Reposted by Debolina Ganguly
Metastasis Research Society @metastasisresearch.bsky.social · 23/12/2024
1/2024 was a big year for metastasis research! Check out our top articles on metastasis research from the year. The field is driving progress and promise for patients with metastatic cancer. Join MRS for monthly updates on all things metastasis: metastasis-research.org/for-research...
metastasis-research.org
Membership | Metastasis Research
184
Reposted by Debolina Ganguly
Yael David @yaeldavidmsk.bsky.social · 04/12/2024
So excited to share our new paper working w/ David Lyden, Han Kim & Jackie Bromberg (WCM), led by the amazing Inbal Wortzel & Ifé Akano where we revealed a new & unexpected function for chromatin on the surface of exosomes in #cancer #metastasis @ Nature Cancer! www.nature.com/articles/s43...
nature.com
Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression - Nature Cancer
Lyden and colleagues find that immune developmental genes, such as apoptotic peptidase activating factor 1 (APAF1), support DNA packaging on the surface of tumor-derived extracellular vesicles that ar...
78219
Reposted by Debolina Ganguly
Débora Vendramini-Costa, Ph.D @debvendramini.bsky.social · 30/11/2024
Hi #immunosky @rafrancescone.bsky.social and I are looking for a postdoc candidate interested in immunology, with experience in flow cytometry, to run projects exploring mechanisms of immunosuppression in pancreatic cancer. Come to beautiful Michigan! Official announcement soon. DM us
25423
Reposted by Debolina Ganguly
Anna Obenauf @obenaufa.bsky.social · 27/11/2024
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
47558141
Reposted by Debolina Ganguly
Science News @scinews.bsky.social · 26/11/2024
Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and Cancer. #NatureAging #Aging #scisky #Medsky #News #Cancer Open Access www.nature.com/articles/s43...
0277
Reposted by Debolina Ganguly
Itai Yanai @itaiyanai.bsky.social · 19/11/2024
There are ~40k postdocs in the US, according to the NIH. While PhD students generally have good support (their committees, external advisors, and classmates), the postdocs do not. To help with this, we're starting the 'Postdoc Night Science' club in Boston this Thursday! (1/3)
27711
Debolina Ganguly @debolina-ganguly.bsky.social · 18/11/2024
It’s great to see this pre-print from the @huoconghuang.bsky.social! Must read for people interested in apCafs!
020
Reposted by Debolina Ganguly
Ashani Weeraratna @ashi-w.bsky.social · 17/11/2024
My first Bluesky meeting post: @megeblad.bsky.social kicking off the AACR tumor-body interactions meeting.
2709
Reposted by Debolina Ganguly
Anna Obenauf @obenaufa.bsky.social · 17/11/2024
🐦➡️🦋 Looking to rebuild your network on Bluesky by reconnecting with your existing X/Twitter contacts? The Skylink browser extension makes it easy! chromewebstore.google.com/detail/sky-f... Thanks @jmschreiber91.bsky.social! #scicomm #cancer #tumorimmunology
chromewebstore.google.com
Sky Follower Bridge - Chrome Web Store
Instantly find and follow the same users from your Twitter follows on Bluesky.
14811